➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Mallinckrodt
McKinsey
Express Scripts
Colorcon

Last Updated: January 22, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Belotecan

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Belotecan?

Belotecan is an investigational drug.

There have been 7 clinical trials for Belotecan. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2009.

The most common disease conditions in clinical trials are Small Cell Lung Carcinoma, Lung Neoplasms, and Uterine Cervical Neoplasms. The leading clinical trial sponsors are Chong Kun Dang Pharmaceutical, Gachon University Gil Medical Center, and Yonsei University.

Recent Clinical Trials for Belotecan
TitleSponsorPhase
A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung CancerGachon University Gil Medical CenterPhase 1/Phase 2
Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb TrialChong Kun Dang PharmaceuticalPhase 2
Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) PatientsChong Kun Dang PharmaceuticalPhase 2

See all Belotecan clinical trials

Clinical Trial Summary for Belotecan

Top disease conditions for Belotecan
Top clinical trial sponsors for Belotecan

See all Belotecan clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Mallinckrodt
McKinsey
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.